{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:12:25Z","timestamp":1760188345828},"reference-count":5,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[1989,1,1]],"date-time":"1989-01-01T00:00:00Z","timestamp":599616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[1989,1]]},"DOI":"10.1016\/0145-2126(89)90128-8","type":"journal-article","created":{"date-parts":[[2004,4,19]],"date-time":"2004-04-19T09:46:32Z","timestamp":1082367992000},"page":"605-607","source":"Crossref","is-referenced-by-count":9,"title":["Treatment of RAEB-t with intensive chemotherapy and GM-CSF"],"prefix":"10.1016","volume":"13","author":[{"given":"Finella","family":"Brito-Babapulle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan A.D.","family":"Lord","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David N.","family":"Whitmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/0145-2126(89)90128-8_BIB1","first-page":"953","article-title":"Myelodysplastic syndromes: natural history and features of prognostic importance","volume":"15","author":"Mufti","year":"1986","journal-title":"Clin. Haemat."},{"key":"10.1016\/0145-2126(89)90128-8_BIB2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2257.1984.tb00532.x","article-title":"The myelodysplastic syndromes","volume":"6","author":"Galton","year":"1984","journal-title":"Clin. Lab. Haemat."},{"issue":"10","key":"10.1016\/0145-2126(89)90128-8_BIB3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJM198809083191001","article-title":"Effect of recombinant human granulocyte-macrophage colony stimulating factor on chemotherapy-induced myelosuppression","volume":"319","author":"Antman","year":"1988","journal-title":"New Engl. J. Med."},{"key":"10.1016\/0145-2126(89)90128-8_BIB4","series-title":"International Society of Haematology Meeting","article-title":"Human granulocyte-macrophage colony stimulating factor (Abstr.)","author":"Monlyn","year":"1988"},{"issue":"25","key":"10.1016\/0145-2126(89)90128-8_BIB5","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1056\/NEJM198712173172501","article-title":"Effects of recombinant human granulocyte-macrophage colony stimulating factor in patients with myelodysplastic syndromes","volume":"317","author":"Vadhan-Raj","year":"1987","journal-title":"New Engl. J. Med."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0145212689901288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0145212689901288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T13:25:08Z","timestamp":1549891508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0145212689901288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,1]]},"references-count":5,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1989,1]]}},"alternative-id":["0145212689901288"],"URL":"https:\/\/doi.org\/10.1016\/0145-2126(89)90128-8","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[1989,1]]}}}